Abordagem das disfunções sexuais femininas

Abstract

Sexual dysfunction prevalence is high among women. However, doctors rarely ask about their patients' sexual life, because they feel uncomfortable or because their knowledge about investigation techniques is insufficient. The PLISSIT model, a useful tool to access human sexual function, is composed by four elements: permission, limited information, specific suggestions, and intensive therapy, that favor dialogue between the doctor and the patient allowing the access to the sexual complaints. The therapeutics consists of counseling measures, drug prescription, basic orientations about sexual function and interventions on anatomic and functional aspects of the sexual apparatus with positive impact in the woman's sexual life. The present review shows how to use it. In addition, many aspects of female sexual dysfunction are discussed, such as prevalence, diagnostic and treatment options for female sexual dysfunction.

Sexual function, anxiety and depression in women with benign breast disease. A case-control study

“…[21][22][23][24] Multiple factors are involved in the pathogenesis of such dysfunction. Decline in the sexual activity of these individuals is primarily attributed to the pain, anxiety and depression that often accompany chronic diseases, as well as to the type of treatment administered.…”

“…That is mainly because health care professionals rarely investigate the issue, as well as because the women themselves feel shame and frustration when discussing such problems. 22 There have been few studies correlating aspects of sexual function with the course of benign gynecological diseases. For example, patients with endometriosis commonly have chronic pelvic pain, which can present together with dysmenorrhea or as dyspareunia per se.…”

“…16 BAI and BDI are both 21-item instruments on which each item is scored from 0 to 3, higher scores indicating greater severity. The severity of anxiety (BAI score) is categorized as follows: minimal (0-7); mild (8)(9)(10)(11)(12)(13)(14)(15); moderate (16)(17)(18)(19)(20)(21)(22)(23)(24)(25); and severe . The severity of depression (BDI score) is categorized as follows: minimal (0-9); mild (10-18); moderate (19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29); and severe (30-63).…”

Conhecimento Sobre Os Efeitos Dos Contraceptivos Hormonais Por Acadêmicas Da Saúde

“…Com isso, conseguiu-se amenizar os sintomas, inclusive da diminuição da libido, em homens (25) . Desse modo, considerar a substituição do contraceptivo pelo método não hormonal também poderia ser uma alternativa (11) .…”

“…O efeito da diminuição da libido entre usuá-rias de métodos contraceptivos hormonais foi explicado pelo aumento dos níveis séricos da proteína Sex Hormone Binding Globulin (SHBG), que transporta os esteroides sexuais. O androgênio, ligado a essa proteína, gera menor disponibilidade da testosterona livre, o que repercute na fase da excitação genital, gerando diminuição da lubrificação vaginal e dispareunia, que culmina na disfunção sexual (11) . …”